Shilpa Medicare

Shilpa Medicare

SHILPAMED

 ₹ 663.35
 ₹ 1.97
0.30%
Healthcare
 ₹ 0.00
(%)1D
Updated: 26 Mar 2025, 03:31:07 pm IST
Stock Score
Open Price
 ₹ 670.48
Prev. Close
 ₹ 661.38
 ₹ 655.88
Day Low
 ₹ 674.05
Day High

 ₹ 433.45
52 Week Low
 ₹ 973.92
52 Week High

Quick Bite

Price To Earnings Ratio

-177.37

Sector PE

64.22

PB Ratio

3.23

Sector PB

8.24

EPS

-3.74

Dividend Yield

0.00

Today's Volume

159.951 K

5 Day Avg. Volume

632.660 K

PEG Ratio

1.16

Market Cap.

₹ 6,670.00 Cr.

News & Events

About Shilpa Medicare

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

Shilpa Medicare Share Price

Shilpa Medicare Limited is an Indian pharmaceutical company. The company's field of activity is research and development, production and sale of oncology drugs and preparations. Its products consist of oncology and non-oncology active ingredients (APIs), oncology formulations, biosimilars, ophthalmic, orodispersible films, biochemical diagnostics, organic intermediates, testing and manufacturing scales, and transdermal patches. It provides oncology APIs and middleware. Its oncology/non-oncology APIs include capecitabine, gemcitabine hydrochloride, axitinib, erlotinib HCL and irinotecan HCL trihydrate in several regulated markets including the US, Europe, Japan, South Korea, Russia, Mexico, Brazil and other emerging markets. Its non-oncology API products include Ambroxol (a mucolytic agent) in Europe and Tranexamic Acid and Ursodeoxycholic Acid in India. The company also manufactures and sells Lenvatinib capsules under the Lenshil brand.

Shilpa Medicare FAQs

How to Buy Shilpa Medicare Share?

up
To purchase Shilpa Medicare shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Shilpa Medicare (ticker symbol: SHILPAMED) on the trading platform provided by your broker and purchase the shares.

What's Shilpa Medicare share price today?

up
The stock price of Shilpa Medicare as of 02 Apr 2025 is ₹663.35

What is the Market Cap of Shilpa Medicare?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 02 Apr 2025, Shilpa Medicare (ticker symbol: SHILPAMED) has a market capitalisation of approximately ₹66,70,00,00,000.00

What is the PE and PB ratio of Shilpa Medicare?

up
Shilpa Medicare Ltd's price-to-book ratio as of 02 Apr 2025 is 3.23, reflecting the market's valuation compared to its asset value. As of 02 Apr 2025, the trailing twelve months P/E (price-to-earnings) ratio is -177.37, indicating the market values the company at around - ₹177.37 for every ₹1 of earnings

What is the 52 Week High and Low of Shilpa Medicare Share?

up
Shilpa Medicare Ltd (SHILPAMED) hit its 52-week high at ₹973.92, and its 52-week low at ₹433.45.
Begin your investment journey today
Login/Register
Start Now